Data / Form D filings / Montlake Bioscience Inc.
Montlake Bioscience Inc.: Form D filing
Montlake Bioscience Inc., a company in Las Vegas, NV, filed a Form D with the SEC in 2018. The latest, on November 1, 2018, reports $11.3 million sold of a $25 million offering to 8 investors.
Find out what Montlake Bioscience Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 222 KAREN AVE #3807, Las Vegas, NV, 89109
- Phone
- (702) 353-7331
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1757681
The full lists. Form D filings in Nevada: 610 rows, $30.50, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 1, 2018 | New notice | $25,000,000 | $11,349,624 | $13,650,376 | 8 | Oct 19, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Baxter Baldwin | Director | |
| Jeremy Kiefer | Executive Officer | |
| Pete Findley | Director |
Other companies in Nevada that filed recently
- Lion Copper Corp. $1.9 million · Nov 3, 2026
- Geomorphic AI $57,500 · Nov 3, 2026
- Five Winds Income Fund LLC offering · Oct 23, 2026
- Chubby Group, Inc. $50 million · Oct 22, 2026
- Kidsy I, a series of Capitalize Investments LLC $83,558 · Oct 7, 2026
- Cytonus Therapeutics I I, a series of Capitalize Investments LLC $643,850 · Oct 7, 2026
- Grounded Health I, a series of Capitalize Investments LLC $32,234 · Oct 7, 2026
- Tarpestry Co. I, a series of Capitalize Investments LLC $51,000 · Oct 7, 2026
- Accelerator QP I, a series of Wefunds LLC $1.6 million · Oct 7, 2026
- Gradatim QP I, a series of Wefunds LLC $4.2 million · Oct 7, 2026
- Autopoiesis I, a series of Capitalize Investments LLC $1 million · Oct 6, 2026
- S26 Orange Fund I, a series of Capitalize Investments LLC $1.6 million · Oct 6, 2026
- Qayinara Animation I I, a series of Capitalize Investments LLC $175,050 · Oct 6, 2026
- Cala Systems I, a series of Capitalize Investments LLC $52,793 · Oct 6, 2026
- Physical Gen I, a series of Capitalize Investments LLC $299,954 · Oct 6, 2026
Every Form D from the week of Oct 29, 2018 · All recent filings in Nevada · All recent Other filings
Read from SEC EDGAR. Amount sold is what Montlake Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.